20/20 GeneSystems, Inc.
9430 Key West Ave,
Rockville, MD 20850
August 17, 2018
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Attn: John Reynolds
Re: | 20/20 GeneSystems, Inc. | |
Offering Statement on Form 1-A | ||
File No. 024-10816 |
Dear Mr. Reynolds:
We understand that the staff of the U.S. Securities and Exchange Commission (the “Commission”) has completed its review of the Offering Statement on Form 1-A (the “Offering Statement”) of 20/20 GeneSystems, Inc. (the “Company”) and we hereby request that the Commission approve the qualification of the Offering Statement as of 4:00 PM Eastern Daylight Time on Friday, August 17, 2018.
We request that we be notified of such qualification by a telephone call to Mr. Louis A. Bevilacqua at (202) 869-0888 ext. 100. We also respectfully request that a copy of the written order from the Commission verifying the date and time of qualification of the Company’s Offering Statement be sent to Bevilacqua PLLC, attention: Mary Sheridan, via email at mary@bevilacquapllc.com.
Sincerely, | ||
20/20 GeneSystems, Inc. | ||
By: | /s/ Jonathan Cohen | |
Jonathan Cohen Chief Executive Officer |
cc: | Louis A. Bevilacqua, Esq. |